Genome sequence and characteristics of plasmid pWH12, a variant of the mcr-1-harbouring plasmid pHNSHP45, from the multi-drug resistant E. coli

Virulence

Volumn 7, Issue 6, 2016, Pages 732-735

  Gao, Rongsui ^a   Wang, Qingjing ^a   Li, Ping ^a   Li, Zhencui ^a   Feng, Youjun ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

colistin; mcr 1; pan drug resistance; pHNSHP45; pWH12

Indexed keywords

AMPICILLIN; CEFOTAXIME; COLISTIN; GENTAMICIN; MCR1 GENE ENCODING PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN; MCR-1 PROTEIN, E COLI;

ANTIBIOTIC RESISTANCE; BACTERIAL GENOME; DISEASE TRANSMISSION; ESCHERICHIA COLI; GENE; GENE SEQUENCE; GENETIC VARIABILITY; GENOMICS; HUMAN; LETTER; MCR1 GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPEN READING FRAME; PLASMID; SEQUENCE HOMOLOGY; DRUG EFFECTS; ESCHERICHIA COLI INFECTION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENOME, BACTERIAL; HUMANS; PLASMIDS;

EID: 84975129414     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.1080/21505594.2016.1193279     Document Type: Letter

References (8)

1. H.Du, L.Chen, Y.W.Tang, B.N.Kreiswirth. Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet Infect Dis 2016; 16(3):287-288; PMID:26842776; http://dx.doi.org/10.1016/S1473-3099(16)00056-6
2. B.B.X.Surbi Malhotra-Kumar, J.D.AnupamJ Das, L.ChristineLammens, B.PatrickButaye, G.HermanGoossens. Colistin resistance gene mcr-1 harboured on a multidrug resistant plasmid. Lancet Infect Dis 2016; 16(3):283-284; PMID:26774247; http://dx.doi.org/10.1016/S1473-3099(16)00012-8
3. Y.Y.Liu, Y.Wang, T.R.Walsh, L.X.Yi, R.Zhang, J.Spencer, Y.Doi, G.Tian, B.Dong, X.Huang, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China:a microbiological and molecular biological study. Lancet Infect Dis 2016; 16(2):161-168; http://dx.doi.org/10.1016/S1473-3099(15)00424-7
4. H.Ye, Y.Li, Z.Li, R.Gao, H.Zhang, R.Wen, G.F.Gao, Q.Hu, Y.Feng. Diversified mcr-1-harbouring plasmid reservoirs confer resistance to colistin in human gut microbiota. mBio 2016; 7(2). pii:e00177-16; PMID:27048797; http://dx.doi.org/10.1128/mBio.00177-16
5. R.L.Nation, J.Li, O.Cars, W.Couet, M.N.Dudley, K.S.Kaye, J.W.Mouton, D.L.Paterson, V.H.Tam, U.Theuretzbacher, et al. Framework for optimisation of the clinical use of colistin and polymyxin B:the Prato polymyxin consensus. Lancet Infect Dis 2015; 15:225-34; PMID:25459221; http://dx.doi.org/10.1016/S1473-3099(14)70850-3
6. D.L.Paterson, P.N.Harris. Colistin resistance:a major breach in our last line of defence. Lancet Infect Dis 2016; 16(2):132-133; PMID:26603171; http://dx.doi.org/10.1016/S1473-3099(15)00463-6
7. X.Yao, Y.Doi, L.Zeng, L.Lv, J.H.Liu. Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1. Lancet Infect Dis 2016; 16(3):288-289; PMID:26842777; http://dx.doi.org/10.1016/S1473-3099(16)00057-8
8. R.Gao, Y.Li, J.Lin, C.Tan, Y.Feng. Unexpected complexity of multidrug resistance in the mcr-1-harbouring Escherichia coli. Sci China Life Sci 2016 May 13; http://dx.doi.org/10.1007/s11427-016-5070-1